Table 1.

MK3 IHC staining and clinicopathologic characteristics of glioma patients.

Variable	Number (N)	MK3 staining
		Low (%)	High (%)	X 2	p
Sex				1.094	0.296
Male	59	37 (62.7)	22 (37.3)
Female	33	17 (51.5)	16 (48.5)
Age				0.042	0.838
<50 years	40	23 (57.5)	17 (42.5)
≥50 years	52	31 (59.6)	21 (40.4)
Tumor size				1.137	0.286
<5 cm	29	19 (65.5)	10 (34.5)
≥5 cm	29	15 (51.7)	14 (48.3)
WHO grade				9.067	0.003
Low (I–II)	25	21 (84.0)	4 (16.0)
High (III–IV)	67	33 (49.3)	34 (50.7)

IHC, immunohistochemistry.